Normal view MARC view ISBD view

Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic.

Druce, Katie L

Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic. [electronic resource] - RMD open 2017 - e000473 p. digital

Publication Type: Journal Article

ISSN: 2056-5933

Standard No.: 10.1136/rmdopen-2017-000473 doi

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)